Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) is a biotechnology company specializing in RNA interference (RNAi) therapeutics ...

There are plenty of high-quality undervalued stocks to buy right now, you just need to know where to look. Here, we highlight ...

A creek expedition turned into an unexpected treasure hunt! Finding this rare arrowhead was a moment straight out of history!

Stock of Sarepta Therapeutics Inc. (NASDAQ: SRPT) surged 38.89% in Tuesday pre-market following the U.S. Food and Drug ...

Chiefs owner and CEO Clark Hunt said Monday the team has not made a final decision on its future stadium, but added there is some “urgency” for a decision.

On Monday, Chiefs Kingdom received a new update from owner Clark Hunt, who described the situation as having “two great ...

FDA recommends lifting the hold on Sarepta's gene therapy Elevidys for ambulatory patients after investigation; ...

While the Kansas City Chiefs coaches and players are focusing on the football side of things, CEO Clark Hunt is deciding on whether or not the Chiefs will reloc ...

FDA probes Elevidys after an 8-year-old's death in Brazil; Sarepta and Roche say the death was unrelated to gene therapy ...

Arrowhead Pharmaceuticals (ARWR) stock gains as company reassures investors about financial obligations required from Sarepta ...

Sarepta Therapeutics' licensing partner Arrowhead Pharmaceuticals said on Wednesday it expects to receive near-term milestone ...

The Stock Market Just Did Something for the 11th Time Since 1984. History Says It Signals a Big Move in the Next Year. Trevor Jennewine, The Motley Fool Thu, Jul 17, 2025, 4:10 AM6 min read ...